1181 - 1190 of 5832 Results
Title
Year
- Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation2022OPENTitle: Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202207022Best OA location URL: https://rupress.org/jcb/article-pdf/221/12/e202207022/1442103/jcb_202207022.pdfCitation Count: 21
-
OPENTitle: Comparison of manual and automated measures of walking speed: Distance and pace matterJournal Name: Experimental GerontologyPublisher: Elsevier BVVol: 170Issue #:Start Page: 111987End Page: 111987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.exger.2022.111987Best OA location URL: https://doi.org/10.1016/j.exger.2022.111987Citation Count: 3
- Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting2022OPENTitle: Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative LightingJournal Name: LEUKOSPublisher: Informa UK LimitedVol: 19Issue #: 3Start Page: 294End Page: 307Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15502724.2022.2123816Best OA location URL: https://doi.org/10.1080/15502724.2022.2123816Citation Count: 7
- Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study2022OPENTitle: Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility StudyJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 31Issue #: 6Start Page: 2741End Page: 2758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1044/2022_ajslp-22-00063Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911128Citation Count: 8
- Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort2022OPENTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://www.nature.com/articles/s41531-022-00404-w.pdfCitation Count: 7
- Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease2022OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 5
- The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function2022OPENTitle: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and functionJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113896End Page: 113896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896Citation Count: 8
- Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures2022OPENTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://www.eneuro.org/content/eneuro/9/6/ENEURO.0325-22.2022.full.pdfCitation Count: 5
- Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease2022OPENTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 11
-
OPENTitle: A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 213End Page: 222Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13603Citation Count: 1